ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report) shares crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $9.08 and traded as high as $13.50. ZIVO Bioscience shares last traded at $13.50, with a volume of 609 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Maxim Group reiterated a “hold” rating on shares of ZIVO Bioscience in a report on Tuesday, June 4th.
View Our Latest Analysis on ZIVO
ZIVO Bioscience Stock Performance
ZIVO Bioscience (NASDAQ:ZIVO – Get Free Report) last posted its quarterly earnings results on Wednesday, August 14th. The biotechnology company reported ($2.78) EPS for the quarter.
About ZIVO Bioscience
ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.
See Also
- Five stocks we like better than ZIVO Bioscience
- How to Start Investing in Real Estate
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- Roth IRA Calculator: Calculate Your Potential Returns
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.